Valeant Pharmaceuticals North America LLC is pleased to announce today that all three products in its newest product line, CeraVe® Baby, have been awarded the National Eczema Association (NEA) Seal of Acceptance™, which maintains rigorous standards for approval. Products include CeraVe® Baby Wash & Shampoo, CeraVe® Baby Moisturizing Lotion, and CeraVe® Baby Diaper Rash Cream. Free of fragrance, parabens, and sulfates, this three-step skincare regimen was developed with pediatric dermatologists to help protect and maintain baby's delicate skin barrier.

John Reed, Senior Brand Manager for Valeant, stated, "We are honored that these CeraVe® Baby products were awarded the NEA Seal of Acceptance™ and we strongly support the National Eczema Association in its mission to help parents make informed decisions when caring for their baby."

Products eligible for the NEA Seal of Acceptance™ are those that have been created or intended for use by people with eczema or severe sensitive skin conditions and that have satisfied the NEA Seal of Acceptance™ criteria. The Seal of Acceptance™ criteria include review of testing results on sensitivity, safety and toxicity, as well as ingredient and formulation data. The NEA Seal helps individuals with eczema make informed purchasing decisions and recognize skincare products that are suitable for eczema or sensitive-skin.

With the inclusion of these three products, 11 CeraVe® products have been awarded the NEA Seal of Acceptance™. Plans to feature the NEA Seal on product packaging are currently in-the-works.